Section Arrow
MENS.NASDAQ
- Jyong Biotech Ltd
Quotes are at least 15-min delayed:2026/07/07 08:12 EDT
Pre Market
Last
 2.11
-0.09 (-4.09%)
Bid
2.11
Ask
2.21
High 2.21 
Low 2.11 
Volume 34 
Regular Hours (Closed)
Last
 2.2
-0.02 (-0.90%)
Day High 
2.3 
Prev. Close
2.22 
1-M High
2.4 
Volume 
99.89K 
Bid
2.11
Ask
2.21
Day Low
2.15 
Open
2.25 
1-M Low
1.5006 
Market Cap 
164.80M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.89 
20-SMA 1.83 
50-SMA 2.01 
52-W High 67 
52-W Low 1.43 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.06/--
Enterprise Value
174.98M
Balance Sheet
Book Value Per Share
-0.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc0.1426+0.0001+0.07%-- 
Pre Market 0.1215 -0.0211 -14.80%
RXRXRecursion Pharmaceuticals3.96+0.16+4.21%-- 
Pre Market 3.93 -0.03 -0.76%
SEERSeer2.19+0.57+35.19%-- 
Pre Market 2.1904 +0.0004 +0.02%
MRNAModerna81.8+2.04+2.56%-- 
Pre Market 82.21 +0.41 +0.50%
GOSSGossamer Bio0.1949+0.0217+12.53%-- 
Pre Market 0.1919 -0.003 -1.54%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.